Aurobindo Pharma Gets 11 Observations From U.S. FDA For Its Telangana Plant
A man rides past an Aurobindo Pharma Ltd. production facility in Jadcherla, Telangana. (Photographer: Prashanth Vishwanathan/Bloomberg)

Aurobindo Pharma Gets 11 Observations From U.S. FDA For Its Telangana Plant

The U.S. Food and Drug Administration has issued a form 483 with 11 observations to Aurobindo Pharma Ltd.’s Unit 16 in Telangana, which makes sterile drug products.The drug regulator had inspected ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.